Browsing by Author "Thiele, Dennis J"

Copper is an essential trace element required by all aerobic organisms as a co-factor for enzymes involved in normal growth, development and physiology. Ctr1 proteins are members of a highly conserved family of copper importers responsible for copper uptake across the plasma membrane. Mice lacking Ctr1 die during embryogenesis from widespread developmental defects, demonstrating the need for adequate copper acquisition in the development of metazoan organisms via as yet uncharacterized mechanisms. The early lethality of the Ctr1 knockout mouse has made it difficult to study the functions of copper and Ctr1 proteins in metazoan development and physiology. Drosophila melanogaster, a genetically tractable system expresses three Ctr1 genes, Ctr1A, Ctr1B and Ctr1C, and may help to further understand the roles of copper and Ctr1 proteins in metazoan development and physiology. Described here is the characterization of Drosophila Ctr1A.

Localization studies using an affinity purified anti-Ctr1A peptide antibody show Ctr1A is predominantly expressed at the plasma membrane in whole embryos and in larval tissues. Ctr1A is an essential gene in Drosophila as loss-of-function mutants, generated by imprecise p-element excision arrest at early larval stages of development. Inductively coupled plasma mass spectroscopy (ICP-MS) demonstrated that whole body copper levels are reduced in Ctr1A mutants and consequently, a number of copper-dependent enzyme deficiencies were detected by in vitro enzyme and cell biological assays. Ctr1A maternal and zygotic mutants have a more severe developmental phenotype and also showed reductions in heart rate, which could be partially rescued by dietary copper supplementation. Heart-specific Ctr1A knockdown flies were subsequently examined for heart rate defects using optical coherence tomography (OCT) and while they did have reduced heart rate measurements, heart contractility was compromised. While investigating tissue-specific requirements for Ctr1A in the development of Drosophila, a genetic interaction between Ctr1A and Ras was observed. Genetic experiments in Drosophila and cell culture experiments in both Drosophila and mammalian cell lines demonstrate a conserved role for Ctr1 proteins and copper as positive modulators of Ras/MAPK pathway signaling. Immunoblot analysis shows that signal transduction is intact until the point at which MEK1/2 phosphorylates ERK1/2. MEK2 protein levels are reduced in copper deficient cells, while MEK1 is able to bind copper-chelated beads, suggesting that these two proteins may be copper-binding proteins. In summary, this work demonstrates that Ctr1A is an essential gene in Drosophila and through characterization studies of Ctr1A, has uncovered conserved roles for Ctr1 proteins and copper in physiological processes and in an important signaling pathway that controls a number of fundamental biological processes.

Copper is an essential element due to its unique ability to cycle between redox states under biological conditions. This property makes copper an ideal catalytic co-factor for enzymes that function in energy generation, iron acquisition, oxygen transport, cellular metabolism, peptide hormone maturation, blood clotting, signal transduction and a variety of other cellular processes. However, excess copper can lead to free radical mediated membrane damage, protein oxidation, and DNA cleavage along with improper metallation of Fe-S clusters. The inability to properly acquire and handle copper is associated with severe genetic diseases of both deficiency and overload as exemplified in Menkes and Wilsons diseases, respectively. Thus, characterizing the acquisition, regulation, and homeostasis of this essential metal is imperative for our understanding of human biology.

The studies presented here utilize a diverse array of techniques including yeast and mouse genetics, recombinant protein expression, purification and biochemical characterization of copper homeostasis proteins, evolutionary genetic analysis, in vitro copper transport assays, and cell culture studies to decipher novel aspects of mammalian copper biology. Critical findings include the discovery of a previously unknown regulator of Copper transporter 1 (Ctr1), and analysis of the evolutionary history of mammalian Ctr proteins, the development of biochemical techniques to probe copper transport mechanisms in a purified system, and the identification of a novel polymorphism in the human Ctr1 gene that has functional consequences. These unique insights lay the foundation for a greater understanding of the basic mechanisms for copper homeostasis in both healthy and diseased states.

Copper (Cu) is a co-factor that is essential for oxidative phosphorylation, protection from oxidative stress, angiogenesis, signaling, iron acquisition, peptide hormone maturation, and a number of other cellular processes. However, excess copper can lead to membrane damage, protein oxidation, and DNA cleavage. To balance the need for copper with the necessity to prevent accumulation to toxic levels, cells have evolved sophisticated mechanisms to regulate copper acquisition, distribution, and storage. The basic components of these regulatory systems are remarkably conserved in most eukaryotes, and this has allowed the use of a variety of model organisms to further our understanding of how Cu is taken into the cell and utilized.

While the components involved in Cu uptake, distribution, and storage are similar in many eukaryotes, evolution has led to differences in how these processes are regulated. For instance, fungi regulate the components involved in Cu uptake and detoxification primarily at the level of transcription while mammals employ a host of post-translational homeostatic mechanisms. In Saccharomyces cerevisiae, transcriptional responses to copper deficiency are mediated by the copper-responsive transcription factor Mac1. Although Mac1 activates the transcription of genes involved in high affinity copper uptake during periods of deficiency, little is known about the mechanisms by which Mac1 senses or responds to reduced copper availability. In the first part of this work, we show that the copper-dependent enzyme Sod1 (Cu,Zn superoxide dismutase) and its intracellular copper chaperone Ccs1 function in the activation of Mac1 in response to an external copper deficiency. Genetic ablation of either CCS1 or SOD1 results in a severe defect in the ability of yeast cells to activate the transcription of Mac1 target genes. The catalytic activity of Sod1 is essential for Mac1 activation and promotes a regulated increase in binding of Mac1 to copper response elements in the promoter regions of genomic Mac1 target genes. Although there is precedent for additional roles of Sod1 beyond protection of the cell from oxygen radicals, the involvement of this protein in copper-responsive transcriptional regulation has not previously been observed.

Higher eukaryotes including mice and humans regulate Cu uptake predominately by means of post-translational control of the localization and stability of the Cu transport proteins. One of these proteins, Ctr1, is the primary means of Cu uptake into the cell, and members of the highly conserved Ctr family of Cu ion channels have been shown to mediate high affinity Cu(I) uptake into cells. In yeast and cultured human cells, Ctr1 functions as a homo-trimer with each monomer harboring an amino-terminal extracellular domain, three membrane spanning domains, a cytoplasmic loop, and a cytoplasmic tail. In addition to the highly conserved Ctr1 Cu ion importer, the baker's yeast S. cerevisiae expresses a related protein called Ctr2. Experimental evidence demonstrates that unlike yeast and mammalian Ctr1, yeast Ctr2 is localized to the vacuolar membrane where it mobilizes Cu stores to the cytoplasm under conditions of Cu limitation.

In mice and humans a gene encoding a protein with significant similarity to the Ctr family has been identified, denoted Ctr2. Publications from others suggest that mammalian Ctr2 may either be a low affinity Cu importer at the plasma membrane or, similar to yeast Ctr2, may mobilize Cu from intracellular organelles such as the lysosome to the cytosol. In agreement with a previous report we found that a fraction of mouse Ctr2 is localized to the plasma membrane and that its membrane topology is the same as Ctr1. Interestingly, over-expression of Ctr2 by stable transfection results in decreased intracellular bioavailable Cu. To begin to understand the physiological role of Ctr2, mice bearing a systemic deletion of the Ctr2 gene were generated. The Ctr2-/- mice are viable but hyper-accumulate Cu in all tissues analyzed. Moreover, protein levels of the Ctr1 Cu importer are dramatically altered in tissues from the Ctr2 knock out mice, and over-expression of Ctr2 in cultured mammalian cells enhances processing of the Ctr1 protein into a less active form. Taken together these results suggest that mammalian Ctr2 functions in the cell as a negative regulator of Cu import via Ctr1.

The ability of iron (Fe) to easily transition between two valence states makes it a preferred co-factor for innumerable biochemical reactions, ranging from cellular energy production, to oxygen transport, to DNA synthesis and chromatin modification. While Fe is highly abundant on the crust of the earth, its insolubility at neutral pH limits its bioavailability. As a consequence, organisms have evolved sophisticated mechanisms of adaptation to conditions of scarce Fe availability.

Studies in the baker's yeast Saccharomyces cerevisiae have shed light into the cellular mechanisms by which cells respond to limited Fe-availability. In response to Fe-deficiency, the transcription factors Aft1 and Aft2 activate a group of genes collectively known as the Fe-regulon. Genes in this group encode proteins involved in the high-affinity plasma membrane Fe-transport and siderophore uptake systems, as well as Fe-mobilization from intracellular stores and heme re-utilization. Concomitant with the up-regulation of the Fe-regulon, a large number of mRNAs encoding Fe-dependent proteins as well as proteins involved in many Fe-dependent processes are markedly down regulated. Thus, in response to low Fe-levels the cell activates the Fe-uptake and mobilization systems, while down-regulating mRNAs involved in highly Fe-demanding processes leading to a genome-wide remodeling of cellular metabolism that permits the funneling of the limiting Fe to essential Fe-dependent reactions.

The Fe-regulon member Cth2 belongs to a family of mRNA-binding proteins characterized by an RNA-binding motif consisting of two tandem zinc-fingers of the CX8CX5CX3H type. Members of this family recognize and bind specific AU-rich elements (AREs) located in the 3'untranslated region (3'UTRs) of select groups of mRNAs, thereby promoting their rapid degradation. In response to Fe-limitation, Cth2 binds ARE sequences within the 3'UTRs of many mRNAs encoding proteins involved in Fe-homeostasis and Fe-dependent processes, thereby accelerating their rate of decay.

Work described in this dissertation demonstrates that the Cth2 homolog, Cth1, is a bona fide member of the Fe-regulon, binds ARE-sequences within the 3'UTRs of select mRNAs and promotes their decay. Cth1 and Cth2 appear to be only partially redundant; Cth1 preferentially targets mRNAs encoding mitochondrial proteins, while Cth2 promotes the degradation of most of Cth1 targets in addition to other mitochondrial and non-mitochondrial Fe-requiring processes. The coordinated activity of Cth1 and Cth2 results in dramatic changes in glucose metabolism. In addition, experiments described in this dissertation indicate that the CTH1 and CTH2 transcripts are themselves subject to ARE-mediated regulation by the Cth1 and Cth2 proteins, creating an auto- and trans-regulatory circuit responsible for differences in their expression. Finally, work described here demonstrates that Cth2 is a nucleocytoplasmic shuttling protein and that shuttling is important for the early determination of cytosolic mRNA-fate.

During development, the precise regulation of the processes of proliferation, migration, and differentiation is required to establish proper organ structure and function and to prevent the deregulation that can lead to disease, such as cancer. Improved understanding of the signals that regulate these processes is therefore necessary to both gain insight into the mechanisms by which organ development proceeds and to identify strategies for treating the consequences of deregulation of these processes. In the cerebellum, some of the factors that regulate these processes have been identified but remain incompletely understood. Our studies have focused on the signals that regulate the migration of cerebellar granule neuron progenitors (GNPs) and the contribution of the SDF-1/CXCR4 signaling axis to postnatal cerebellar development. Using conditional knockout mice to delete CXCR4 specifically in GNPs, we show that loss of CXCR4 results in premature migration of a subset of GNPs throughout postnatal development that are capable of proliferation and survival outside of their normal mitogenic niche. Loss of CXCR4 also causes a reduction in the activity of the Sonic hedgehog (SHH) pathway (the primary mitogen for GNPs) but does not affect GNP proliferation, differentiation, or capacity for tumor formation. Our data suggest that while other factors likely contribute, SDF-1/CXCR4 signaling is necessary for proper migration of GNPs throughout cerebellar development.

In addition to understanding the signals that regulate normal development, the identification of vulnerabilities of established tumors is also necessary to improve cancer treatment. One strategy to improve treatment involves targeting the cells that are critical for maintaining tumor growth, known as tumor-propagating cells (TPCs). In the context of the cerebellar tumor medulloblastoma (MB), we have previously identified a population of TPCs in tumors from patched mutant mice that express the cell surface carbohydrate antigen CD15/SSEA-1. Here, we employed multiple approaches in an effort to target these cells, including a biochemical approach to identify molecules that carry the CD15 carbohydrate epitope as well as an immunotoxin approach to specifically target CD15-expressing cells. Unfortunately, these strategies were ultimately unsuccessful, but an alternative approach that recognized a vulnerability of CD15+ cells was identified. We show that CD15+ cells express elevated levels of genes associated with the G2/M phases of the cell cycle, progress more rapidly through the cell cycle than CD15- cells, and contain an increased proportion of cells in G2/M. Exposure of tumor cells to inhibitors of Aurora and Polo-like kinases, key regulators of G2/M, induces cell cycle arrest, apoptosis and enhanced sensitivity to conventional chemotherapy, and treatment of tumor-bearing mice with these agents significantly inhibits tumor progression. Importantly, cells from human patient-derived MB xenografts are also sensitive to Aurora and Polo-like kinase inhibitors. Our findings suggest that targeting G2/M regulators may represent a novel approach for the treatment of human MB.

Proteotoxic stress is implicated in numerous human diseases including neurodegeneration, cancer, and diabetes. Unfortunately, our mechanistic understanding of the cellular response to proteotoxic stress is limited. A critical feature of the cellular stress response is the activation of Heat Shock Transcription Factors (HSFs) that regulate the expression of numerous genes involved in protein folding, protein degradation, and cellular survival. The studies presented here utilize a diverse array of techniques including yeast genetics, recombinant protein expression and purification, biochemical analysis of protein-DNA interactions, x-ray crystallography, in vitro post-translational modification, and mammalian cell culture to illuminate novel aspects of HSF biology. Critical findings include understanding key principles of HSF-DNA interactions, identification of a novel negative regulator of HSF activity, and identification of structural features of HSF paralogs that enable precise combinatorial regulation. These unique insights lay the foundation for a greater understanding of HSF in specific cellular contexts and disease states.